There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Although β-blockers reduce mortality after acute myocardial infarction (AMI), early
reports linking β-blocker use with subsequent depression have potentially limited
their use in vulnerable patients. We sought to provide empirical evidence to support
or refute this concern by examining the association between β-blocker initiation and
change in depressive symptoms in AMI patients.